EuBiologics Announces Investor Relations Meeting for July 2026
EuBiologics announced that it will hold an investor relations meeting for securities firm fund managers on July 8-9, 2026 in Yeouido, Seoul, in a group meeting format.
The IR aims to enhance understanding of the company and its business progress, covering business status, R&D plans, and Q&A.
The event is sponsored by Seoul IR, and IR materials will be posted on the KRX KIND system on July 8, 2026.
[AI Summary]This IR meeting notice does not include any capital changes or dividend policy adjustments that would directly impact corporate value. Therefore, it is evaluated as a neutral event for stock price outlook.